For storage after reconstitution, keep at 2-8 degrees C and use within 28 days
Results indicated rotenone induced robust ROS generation (Fig
The dosage of phentermine requires reduction in people with severe kidney impairment and it should be avoided in people with end-stage kidney disease
Multifaceted roles of glutathione and glutathione-based systems in carcinogenesis and anticancer drug resistance
Specifically, people who need a reduced form of glutathione are people who have diseases such as liver cirrhosis, lung disease, autoimmune diseases, and heart diseases
Based on available Phase 2 data, both agents share a side-effect profile broadly consistent with other medicines acting on metabolic hormone pathways, though the triple-agonist mechanism of retatrutide introduces some additional considerations